Construct: ORF ccsbBroadEn_05771

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF011074.1_s300c1, BRDN0000457031
DNA Barcode:
None
Epitope Tag:
None
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
ADARB1 (104)

Vector Information:

Vector Backbone:
pDONR223
Pol II Cassette 1:
n/a
Pol II Cassette 2:
n/a
Selection Marker:
n/a
Visible Reporter:
n/a
Epitope Tag:
n/a

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 104 ADARB1 adenosine deaminase RNA spe... NM_001112.4 99.9% 99.8% 671T>C;1962G>A
2 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028255.1 99.9% 99.8% 671T>C;1962G>A
3 human 104 ADARB1 adenosine deaminase RNA spe... NM_001160230.2 96% 95.7% (many diffs)
4 human 104 ADARB1 adenosine deaminase RNA spe... NM_001346688.1 96% 95.7% (many diffs)
5 human 104 ADARB1 adenosine deaminase RNA spe... NM_015833.4 94.5% 94.4% 671T>C;1395_1514del;2082G>A
6 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028247.1 94.5% 94.4% 671T>C;1395_1514del;2082G>A
7 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028248.1 94.5% 94.4% 671T>C;1395_1514del;2082G>A
8 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028249.1 94.5% 94.4% 671T>C;1395_1514del;2082G>A
9 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028250.1 94.5% 94.4% 671T>C;1395_1514del;2082G>A
10 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028251.1 94.5% 94.4% 671T>C;1395_1514del;2082G>A
11 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028245.2 93.3% 93.3% 1_147del;818T>C;2109G>A
12 human 104 ADARB1 adenosine deaminase RNA spe... XM_006723954.2 91% 91% (many diffs)
13 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028243.1 91% 91% (many diffs)
14 human 104 ADARB1 adenosine deaminase RNA spe... NM_015834.4 90.8% 90.5% (many diffs)
15 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028254.1 90.8% 90.5% (many diffs)
16 human 104 ADARB1 adenosine deaminase RNA spe... XM_011529425.2 90.7% 90.6% (many diffs)
17 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028253.2 89.7% 89.4% (many diffs)
18 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028242.2 88.6% 88.6% (many diffs)
19 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028246.1 87.5% 87.2% (many diffs)
20 human 104 ADARB1 adenosine deaminase RNA spe... XM_024452043.1 85.7% 84% (many diffs)
21 human 104 ADARB1 adenosine deaminase RNA spe... XM_017028244.2 85.1% 84.9% (many diffs)
22 human 104 ADARB1 adenosine deaminase RNA spe... NM_001346687.2 81.4% 79.7% (many diffs)
23 human 104 ADARB1 adenosine deaminase RNA spe... NR_144483.2 57.7% (many diffs)
24 human 104 ADARB1 adenosine deaminase RNA spe... XM_011529432.1 46.5% 46.5% 0_1ins1068;327_446del;1014G>A
25 human 104 ADARB1 adenosine deaminase RNA spe... NR_027674.2 42.5% (many diffs)
26 human 104 ADARB1 adenosine deaminase RNA spe... XR_001754792.2 41.8% (many diffs)
27 human 104 ADARB1 adenosine deaminase RNA spe... NR_073200.2 41.5% (many diffs)
28 human 104 ADARB1 adenosine deaminase RNA spe... NR_027673.1 41.4% (many diffs)
29 human 104 ADARB1 adenosine deaminase RNA spe... XR_001754791.2 41.4% (many diffs)
30 human 104 ADARB1 adenosine deaminase RNA spe... XR_001754787.2 38.6% (many diffs)
31 human 104 ADARB1 adenosine deaminase RNA spe... XR_001754793.2 37.9% (many diffs)
32 human 104 ADARB1 adenosine deaminase RNA spe... NR_027672.2 32.2% (many diffs)
33 human 104 ADARB1 adenosine deaminase RNA spe... XR_001754786.2 31.2% (many diffs)
34 mouse 110532 Adarb1 adenosine deaminase, RNA-sp... NM_130895.3 87.7% 94.8% (many diffs)
35 mouse 110532 Adarb1 adenosine deaminase, RNA-sp... XM_006513065.1 86.7% 93.4% (many diffs)
36 mouse 110532 Adarb1 adenosine deaminase, RNA-sp... NM_001024837.2 86.5% 93.5% (many diffs)
37 mouse 110532 Adarb1 adenosine deaminase, RNA-sp... XM_006513064.1 85.6% 92.1% (many diffs)
38 mouse 110532 Adarb1 adenosine deaminase, RNA-sp... XM_006513063.3 80.3% 86.9% (many diffs)
39 mouse 110532 Adarb1 adenosine deaminase, RNA-sp... XM_006513062.3 79.3% 85.8% (many diffs)
40 mouse 110532 Adarb1 adenosine deaminase, RNA-sp... NR_021486.1 27.8% (many diffs)
41 mouse 110532 Adarb1 adenosine deaminase, RNA-sp... NR_004429.1 27.7% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
66
ORF end:
2169
ORF length:
2103
Sequence:
1gttcgttgca acaaattgat gagcaatgct tttttataat gccaaCTTTG TACAAAAAAG
61TTGGCATGGA TATAGAAGAT GAAGAAAACA TGAGTTCCAG CAGCACTGAT GTGAAGGAAA
121ACCGCAATCT GGACAACGTG TCCCCCAAGG ATGGCAGCAC ACCTGGGCCT GGCGAGGGCT
181CTCAGCTCTC CAATGGGGGT GGTGGTGGCC CCGGCAGAAA GCGGCCCCTG GAGGAGGGCA
241GCAATGGCCA CTCCAAGTAC CGCCTGAAGA AAAGGAGGAA AACACCAGGG CCCGTCCTCC
301CCAAGAACGC CCTGATGCAG CTGAATGAGA TCAAGCCTGG TTTGCAGTAC ACACTCCTGT
361CCCAGACTGG GCCCGTGCAC GCGCCTTTGT TTGTCATGTC TGTGGAGGTG AATGGCCAGG
421TTTTTGAGGG CTCTGGTCCC ACAAAGAAAA AGGCAAAACT CCATGCTGCT GAGAAGGCCT
481TGAGGTCTTT CGTTCAGTTT CCTAATGCCT CTGAGGCCCA CCTGGCCATG GGGAGGACCC
541TGTCTGTCAA CACGGACTTC ACATCTGACC AGGCCGACTT CCCTGACACG CTCTTCAATG
601GTTTTGAAAC TCCTGACAAG GCGGAGCCTC CCTTTTACGT GGGCTCCAAT GGGGATGACT
661CCTTCAGTTC CAGCGGGGAC CTCAGCTTGT CTGCTTCCCC GGTGCCTGCC AGCCTAGCCC
721AGCCTCCTCT CCCTGCCTTA CCACCATTCC CACCCCCGAG TGGGAAGAAT CCCGTGATGA
781TCTTGAACGA ACTGCGCCCA GGACTCAAGT ATGACTTCCT CTCCGAGAGC GGGGAGAGCC
841ATGCCAAGAG CTTCGTCATG TCTGTGGTCG TGGATGGTCA GTTCTTTGAA GGCTCGGGGA
901GAAACAAGAA GCTTGCCAAG GCCCGGGCTG CGCAGTCTGC CCTGGCCGCC ATTTTTAACT
961TGCACTTGGA TCAGACGCCA TCTCGCCAGC CTATTCCCAG TGAGGGTCTT CAGCTGCATT
1021TACCGCAGGT TTTAGCTGAC GCTGTCTCAC GCCTGGTCCT GGGTAAGTTT GGTGACCTGA
1081CCGACAACTT CTCCTCCCCT CACGCTCGCA GAAAAGTGCT GGCTGGAGTC GTCATGACAA
1141CAGGCACAGA TGTTAAAGAT GCCAAGGTGA TAAGTGTTTC TACAGGAACA AAATGTATTA
1201ATGGTGAATA CATGAGTGAT CGTGGCCTTG CATTAAATGA CTGCCATGCA GAAATAATAT
1261CTCGGAGATC CTTGCTCAGA TTTCTTTATA CACAACTTGA GCTTTACTTA AATAACAAAG
1321ATGATCAAAA AAGATCCATC TTTCAGAAAT CAGAGCGAGG GGGGTTTAGG CTGAAGGAGA
1381ATGTCCAGTT TCATCTGTAC ATCAGCACCT CTCCCTGTGG AGATGCCAGA ATCTTCTCAC
1441CACATGAGCC AATCCTGGAA GAACCAGCAG ATAGACACCC AAATCGTAAA GCAAGAGGAC
1501AGCTACGGAC CAAAATAGAG TCTGGTGAGG GGACGATTCC AGTGCGCTCC AATGCGAGCA
1561TCCAAACGTG GGACGGGGTG CTGCAAGGGG AGCGGCTGCT CACCATGTCC TGCAGTGACA
1621AGATTGCACG CTGGAACGTG GTGGGCATCC AGGGATCCCT GCTCAGCATT TTCGTGGAGC
1681CCATTTACTT CTCGAGCATC ATCCTGGGCA GCCTTTACCA CGGGGACCAC CTTTCCAGGG
1741CCATGTACCA GCGGATCTCC AACATAGAGG ACCTGCCACC TCTCTACACC CTCAACAAGC
1801CTTTGCTCAG TGGCATCAGC AATGCAGAAG CACGGCAGCC AGGGAAGGCC CCCAACTTCA
1861GTGTCAACTG GACGGTAGGC GACTCCGCTA TTGAGGTCAT CAACGCCACG ACTGGGAAGG
1921ATGAGCTGGG CCGCGCGTCC CGCCTGTGTA AGCACGCGTT GTACTGTCGC TGGATGCGTG
1981TGCACGGCAA GGTTCCCTCC CACTTACTAC GCTCCAAGAT TACCAAACCC AACGTGTACC
2041ATGAGTCCAA GCTGGCGGCA AAGGAGTACC AGGCCGCCAA GGCGCGTCTG TTCACAGCCT
2101TCATCAAGGC GGGGCTGGGG GCCTGGGTGG AGAAGCCCAC CGAGCAGGAC CAGTTCTCAC
2161TCACGCCCTG CCCAACTTTC TTGTACAAAG TTGGcattat aagaaagcat tgcttatcaa
2221tttgttgcaa cgaac

Download FASTA (ORF) (Full)

GPP Web Portal Terms of Service

Effective Date: December 8, 2025
By using this site, you agree to our terms and conditions below.

Overview of Terms

The data made available on this website were generated for research purposes and are not intended for clinical or commercial uses. Commercial use (or other use for profit-making purposes) of the GPP Web Portal and its tools, is not permitted under these terms and may require a separate license agreement from Broad or its contributors. For more information, please contact partnering@broadinstitute.org.

The original data may be subject to rights claimed by third parties, including but not limited to, patent, copyright, other intellectual property rights, biodiversity-related access and benefit-sharing rights. It is the responsibility of users of Broad Institute services to ensure that their use of the data does not infringe any of the rights of such third parties.

Any questions or comments concerning these Terms of Use can be addressed to: legal@broadinstitute.org.

By accessing and viewing this GPP Web Portal, you agree to the following terms and conditions:

Attribution

You agree to acknowledge the Broad Institute (e.g., in publications, services or products) for any of your use of its online services, databases or software in accordance with good scientific practice. You agree to use the acknowledgment wording provided for the relevant tools as indicated on the FAQ for each tool.

Updating the Terms of Use

We reserve the right to update these Terms of Use at any time. When alterations are inevitable, we will attempt to give reasonable notice of any changes by placing a notice on our website, but you may wish to check each time you use the website. The date of the most recent revision will appear on this, the "GPP Web Portal Terms of Use" page. If you do not agree to these changes, please do not continue to use our online services. We will also make available an archived copy of the previous Terms of Use for comparison.

Indemnification and Disclaimer of Warranties

You are using this GPP Web Portal at your own risk, and you hereby agree to hold Broad and its contributors and their trustees, directors, officers, employees, and affiliated investigators harmless for any third party claims which may arise from your use of the GPP Web Portal, the tools available therein, or any portion thereof. Further, you agree to indemnify Broad, its contributors, and its and their trustees, directors, officers, employees, affiliated investigators, students, and affiliates for any loss, costs, claims, damages, or other liabilities arising from any unpermitted commercial or profit-making use you make of the GPP Web Portal. The GPP Web Portal is a research tool and is provided "as is". Broad does not represent that the GPP Web Portal is free of errors or bugs or suitable for any particular tasks.

ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS ARE DISCLAIMED. IN NO EVENT SHALL BROAD OR ITS CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THE GPP WEB PORTAL, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

Governing Law

The terms and conditions herein shall be construed, governed, interpreted, and applied in accordance with the internal laws of the Commonwealth of Massachusetts, U.S.A. Furthermore, by accessing, downloading, or using the Database, You consent to the personal jurisdiction of, and venue in, the state and federal courts within Massachusetts with respect to Your download or use of the Database.